Transgender In Transition
ConditionGender Incongruence
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversitätsklinikum Hamburg-Eppendorf
About this trial
Prospective trial in gender dysphoric patients who undergo gender-affirming hormone therapy, aiming to investigate psychological, biological and behavioural consequences of hormonal therapy.
Eligibility criteria
Qualifiers
diagnosis of gender incongruence (ICD-11) or gender dysphoria (DSM-5)
written informed consent following adequate oral and written Information
before gender-affirming hormonal treatment
Disqualifiers
pregnancy or breast-feeding
Trial design
Treatments tested in this trial
- Online surveys
Treatment groups
750 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov